| | Identification | Back Directory |  | [Name] 
 (SAR1,ILE4,8)-ANGIOTENSIN II
 |  | [CAS] 
 185461-45-4
 |  | [Synonyms] 
 (SAR1,ILE4,8)-ANGIOTENSIN II
 SAR-ARG-VAL-ILE-ILE-HIS-PRO-ILE
 SAR-ARG-VAL-ILE-ILE-HIS-PRO-ILE-OH
 REF DUPL: Sar-Arg-Val-Ile-Ile-His-Pro-Ile-OH
 (Sar 1,Ile4·8)-Angiotensin II trifluoroacetate salt Sar-Arg-Val-Ile-Ile-His-Pro-Ile-OH trifluoroacetate salt
 |  | [Molecular Formula] 
 C43H75N13O9
 |  | [MDL Number] 
 MFCD08458670
 |  | [MOL File] 
 185461-45-4.mol
 |  | [Molecular Weight] 
 918.14
 | 
 | Chemical Properties | Back Directory |  | [density ] 
 1.34±0.1 g/cm3(Predicted)
 |  | [form ] 
 Solid
 |  | [pka] 
 3.72±0.22(Predicted)
 |  | [color ] 
 White to off-white
 |  | [Sequence] 
 {Sar}-Arg-Val-Ile-Ile-His-Pro-Ile
 | 
 | Hazard Information | Back Directory |  | [Uses] 
 (Sar1,Ile4,8)-Angiotensin II is a functionally selective angiotensin II type 1 receptor (AT1R) agonist. (Sar1,Ile4,8)-Angiotensin II potentiates insulin-stimulated insulin receptor (IR) signaling and glycogen synthesis. (Sar1,Ile4,8)-Angiotensin II potentiates insulin-stimulated phosphorylation of Akt and GSK3α/β[1].
 |  | [IC 50] 
 Angiotensin II Type 1
 |  | [References] 
 [1] Sanni SJ, et al. [Sar1, Ile4, Ile8]-angiotensin II Potentiates Insulin Receptor Signalling and Glycogen Synthesis in Hepatocytes. Basic Clin Pharmacol Toxicol. 2018 May;122(5):460-469. DOI:10.1111/bcpt.12937
 | 
 | 
                    
                        
                            | Company Name: | BOC Sciences |  
                            | Tel: | 1-631-485-4226; 16314854226 |  
                            | Website: | https://www.bocsci.com |  |